Ads
related to: how to treat type 1 diabetesalternativebee.com has been visited by 100K+ users in the past month
temu.com has been visited by 1M+ users in the past month
topdealweb.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
The mainstay of type 1 diabetes treatment is the regular injection of insulin to manage hyperglycemia. [39] Injections of insulin via subcutaneous injection using either a syringe or an insulin pump are necessary multiple times per day, adjusting dosages to account for food intake, blood glucose levels and physical activity. [39]
Diabetes mellitus type 1 is a disease caused by the lack of insulin. Thus, Insulin is the main treatment agent for type 1 and is typically administered via subcutaneous injection. Diabetes mellitus type 2 is a disease of insulin resistance by cells. Type 2 diabetes mellitus is the most common type of diabetes.
As a medication, insulin is any pharmaceutical preparation of the protein hormone insulin that is used to treat high blood glucose. [6] Such conditions include type 1 diabetes, type 2 diabetes, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. [6]
Type 1 diabetes can occur at any age, and a significant proportion is diagnosed during adulthood. Latent autoimmune diabetes of adults (LADA) is the diagnostic term applied when type 1 diabetes develops in adults; it has a slower onset than the same condition in children. Given this difference, some use the unofficial term "type 1.5 diabetes ...
Diabetes management. The term diabetes includes several different metabolic disorders that all, if left untreated, result in abnormally high concentrations of a sugar called glucose in the blood. Diabetes mellitus type 1 results when the pancreas no longer produces significant amounts of the hormone insulin, usually owing to the autoimmune ...
It was the first oral treatment, in combination with insulin, to treat type 1 diabetes in the UK and EU. Empagliflozin, approved in the United States in August 2014, under the brand name Jardiance by Boehringer Ingelheim. [30] Of the gliflozins, empagliflozin and tofogliflozin have the highest specificity for SGLT2 inhibition. [1]
Ads
related to: how to treat type 1 diabetesalternativebee.com has been visited by 100K+ users in the past month
temu.com has been visited by 1M+ users in the past month
topdealweb.com has been visited by 10K+ users in the past month